Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CCM
CCM logo

CCM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Concord Medical Services Holdings Ltd (CCM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.800
1 Day change
2.56%
52 Week Range
10.770
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CCM is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is weak technically, has no supportive news or catalyst, no bullish proprietary signal, and no clear financial or analyst momentum provided. For an impatient investor who does not want to wait for a better setup, this is still not an attractive entry.

Technical Analysis

The trend is bearish to weak. MACD histogram is negative and expanding, showing downside momentum is still building. RSI at 35.813 is neutral but leaning weak, not oversold enough to indicate a strong rebound setup. Moving averages are converging, which suggests indecision, but the current price action remains below the pivot of 5.003 and very close to support at 4.373. The stock is trading at 4.39 after a -2.66% regular market move, which confirms pressure remains on the downside. Overall, technicals do not support an immediate buy.

Positive Catalysts

  • No news in the recent week. Similar-pattern stock behavior suggests a modest short-term rebound probability, with 0.27% expected next day, 0.73% next week, and 3.39% next month, but this is not a strong catalyst. Hedge funds are neutral and insiders are neutral, so there is no clear accumulation signal. No recent congress trading data available.

Neutral/Negative Catalysts

  • Negative MACD momentum, weak price action, and no recent news are the main negatives. The stock closed at 4.39, just above support at 4.373, leaving little margin for error. No valuation data, no financial snapshot, and no bullish analyst revisions were provided. Hedge fund and insider activity are neutral, and there is no supportive AI Stock Picker or SwingMax signal.

Financial Performance

No usable latest-quarter financial snapshot was provided due to an error, so there is no reliable quarter-over-quarter or year-over-year growth assessment available. Latest quarter season could not be identified from the data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no evidence of improving Wall Street sentiment. Based on the available information, pros would struggle to justify a bullish view because there is no catalyst, no positive revision trend, and no financial momentum data. The cons view is stronger: weak technicals, no news, and no bullish proprietary signal.

Wall Street analysts forecast CCM stock price to rise
Analyst Rating
0
Wall Street analysts forecast CCM stock price to rise
Buy
Hold
Sell
0
Current: 4.680
sliders
Low
0
Averages
0
High
0
0
Current: 4.680
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch